Three healthcare organizations made personnel moves to end the week.

Form Bio announced Friday morning that Linda Murray will serve as chief financial officer. As the financial head, Murray will be tasked with “the establishment and scaling of the financial and operating infrastructure” for Form Bio. 

Murray joins the computational life sciences platform from Cambridge Mobile Telematics, where she served as VP of financial planning and analysis.

“We are excited to announce this important addition to Form Bio’s leadership team as we enter an exciting time in our development and evolution; we’re growing rapidly as more cell and gene therapy companies discover what our advanced software can do to help them solve their most pressing challenges and ultimately elevate human health,” Form Bio co-CEO Kent Wakeford said in a statement. “Linda’s strong financial planning and analysis background, coupled with her depth of experience in both healthcare and technology, will be a crucial asset as we build and scale the company.”

For its part, Waystar elevated Missy Miller to chief marketing officer. Miller previously served as SVP of marketing of the healthcare technology company and has more than 16 years of industry experience.

“Missy is a proven leader with strong experience delivering strategic marketing plans that drive growth,” Waystar CEO Matt Hawkins said in a statement. “She will continue to play an important role as we grow further and provide innovative technology to shape the future of healthcare payments.”

Finally, BGB Group promoted Teresa Day as president of the agency and tapped Art Chavez, a former Juice Pharma leader, as chief of business integration. Day, who has been with BGB since 2010, previously served as BGB’s chief operating officer.

In addition to Day’s elevation, BGB hired two account management EVPs, with Matt Paré joining from Omnicom Health Group and Ryan Taggart joining from Klick Health.

“These changes and additions to our leadership team will build on our strengths and bring in new expertise and perspective to the emerging trends that we are seeing in pharma marketing,” Gregory Passaretti, a founding partner at BGB, said in a statement. “Our competitive advantage has always been our people. What sets them apart and makes us invaluable to our clients is their unique blend of scientific acumen, creativity, and their push for innovative ways to deliver messaging that resonates with providers and patients.”